ALEC Alector Inc

USD 5.09 0.02 0.394477
Icon

Alector Inc (ALEC) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 5.09

+0.02 (+0.39)%

USD 0.49B

0.41M

USD 12.00(+135.76%)

USD 7.50 (+47.35%)

Icon

ALEC

Alector Inc (USD)
COMMON STOCK | NSD
USD 5.09
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.49B

USD 7.50 (+47.35%)

USD 5.09

Alector Inc (ALEC) Stock Forecast

Show ratings and price targets of :
USD 12.00
(+135.76%)

Based on the Alector Inc stock forecast from 3 analysts, the average analyst target price for Alector Inc is USD 12.00 over the next 12 months. Alector Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Alector Inc is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, Alector Inc’s stock price was USD 5.09. Alector Inc’s stock price has changed by -18.30% over the past week, -15.17% over the past month and -21.99% over the last year.

No recent analyst target price found for Alector Inc
No recent average analyst rating found for Alector Inc

Company Overview Alector Inc

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, an immune activity in the brain with genetic links to multiple neurodegenerative disorders, which is in Phase III clinical tr...Read More

https://www.alector.com

131 Oyster Point Boulevard, South San Francisco, CA, United States, 94080

244

December

USD

USA

Adjusted Closing Price for Alector Inc (ALEC)

Loading...

Unadjusted Closing Price for Alector Inc (ALEC)

Loading...

Share Trading Volume for Alector Inc Shares

Loading...

Compare Performance of Alector Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ALEC

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Alector Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +0.38 (+0.10%) USD107.38B 29.93 21.06

ETFs Containing ALEC

Symbol Name ALEC's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Alector Inc (ALEC) Stock

Based on ratings from 3 analysts Alector Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 3 buy, sell and hold ratings.

Unfortunately we do not have enough data on ALEC's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for ALEC is USD 12.00 over the next 12 months. The maximum analyst target price is USD 15 while the minimum anlayst target price is USD 9.

ALEC stock's Price/Earning ratio is 15.22. Our analysis grades ALEC stock's Price / Earning ratio at F. This means that ALEC stock's Price/Earning ratio is above 65.99999999999999% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ALEC may be a overvalued for its sector.

The last closing price of ALEC's stock was USD 5.09.

The most recent market capitalization for ALEC is USD 0.49B.

Based on targets from 3 analysts, the average taret price for ALEC is projected at USD 12.00 over the next 12 months. This means that ALEC's stock price may go up by +135.76% over the next 12 months.

We can't find any ETFs which contains Alector Inc's stock.

As per our most recent records Alector Inc has 244 Employees.

Alector Inc's registered address is 131 Oyster Point Boulevard, South San Francisco, CA, United States, 94080. You can get more information about it from Alector Inc's website at https://www.alector.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...